{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:23:24Z","timestamp":1761895404079},"reference-count":9,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T00:00:00Z","timestamp":1326067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1111\/j.1365-2141.2011.09016.x","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T07:47:42Z","timestamp":1326095262000},"page":"407-410","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib\u2010resistant chronic myeloid leukaemia patient harbouring the <i>BCR\u2010ABL1<\/i> T315I gatekeeper mutation"],"prefix":"10.1111","volume":"157","author":[{"given":"Marie\u2010Magdelaine","family":"Coude","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile","family":"Luycx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie\u2010Estelle","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile","family":"Maarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Dombret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Michel","family":"Cayuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Rea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,9]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.210.210","article-title":"A phase 1 trial of oral ponatinib (AP24534) in patients with refractory chronic myelogenous leukemia (CML) and other hematologic malignancies: emerging safety and clinical response findings","volume":"116","author":"Cortes J.","year":"2010","journal-title":"Blood"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1062538"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-094508"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404772"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20975"},{"key":"e_1_2_4_7_1","first-page":"S2","article-title":"Treatment of chronic phase (CP) chronic myeloid leukaemia (CML) patients who harbour the BCR\u2010ABL T315I mutation with subcutaneous omacetaxine results in improved survival compared to historical data","volume":"96","author":"Nanda N.","year":"2011","journal-title":"Haematologica"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2010.n.073"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099480"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.01.007"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2011.09016.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2011.09016.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:14:49Z","timestamp":1698754489000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2011.09016.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,9]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1111\/j.1365-2141.2011.09016.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2011.09016.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,9]]},"assertion":[{"value":"2012-01-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}